Audentes Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Audentes Therapeutics, Inc.
CIK #0001628738
EDGAR Form CIK 2011 - 2025
10-K [0001628738]
10-Q [0001628738]
3 [0001628738]
4 [0001628738]
8-K [0001628738]
D [0001628738]
SC 13D [0001628738]
SC 13G [0001628738]
Form 13D/13G Filer Form 13D/13G Subject Filed
Audentes Therapeutics Inc Taysha Gene Therapies Inc [2022-10-31]
Vanguard Group Inc Audentes Therapeutics Inc [2020-02-11]
Great Point Partners LLC Audentes Therapeutics Inc [2019-09-16]
Redmile Group LLC Audentes Therapeutics Inc [2019-02-14]
BlackRock Inc Audentes Therapeutics Inc [2019-02-08]
Partner Fund Management LP Audentes Therapeutics Inc [2018-10-29]
Price T Rowe Associates Inc /MD/ Audentes Therapeutics Inc [2018-02-14]
Wellington Management Group LLP Audentes Therapeutics Inc [2018-02-12]
FMR LLC Audentes Therapeutics Inc [2017-10-10]
Adage Capital Partners GP LLC Audentes Therapeutics Inc [2017-04-27]
View All
Form 3/4/5 Subject 2011 - 2025
Taysha Gene Therapies, Inc.
Astellas Pharma Inc.
Audentes Therapeutics, Inc.
Soloway Thomas P
Smith Julie
Schuetz Thomas J.
Patterson Matthew R
Mosbrooker Eric
Morrison Scott W
Meltz Mark A
View All
Terms | Privacy | Guide
tony@aum13f.com